相关实验视频
Updated: Sep 14, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.6K
早期后深度大脑刺激在帕金森病的精神病不良事件:一个叙事审查
Arteen Ahmed1, Matthew Butler2, Camille Wratten3
1Psychological Medicine, King's College Hospital NHS Foundation Trust, London, UK arteen.1.ahmed@kcl.ac.uk.
Journal of neurology, neurosurgery, and psychiatry
|July 24, 2025
概括
在帕金森病 (PD) 深度大脑刺激 (DBS) 后,早期精神问题很常见. 这些事件通常通过调整DBS参数或药物来改善,突出显示需要监测情绪健康.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 精神病学是一个精神病学.
背景情况:
- 深度大脑刺激 (DBS) 治疗帕金森病 (PD) 的运动症状.
- 精神病学因素显著影响DBS手术后的生活质量.
- 亚thalamic核 (STN) 和内部球 (GPi) 是主要的DBS目标.
研究的目的:
- 在PD患者的DBS后审查早期 (<2周) 的精神病不良事件 (AEs).
- 评估这些AEs的患病率和对先前存在的精神症状的影响.
- 探索DBS向和参数对精神病治疗结果的影响.
主要方法:
- 一个叙事审查研究的早期精神病的结果后,PD的DBS.
- 在多个数据库中进行了全面的文献搜索.
- 从148项相关研究中,包括了55项专注于早期精神病结果的研究.
主要成果:
- 早期的术后精神病学AE在PD的DBS中很常见,通常在几天内出现,通常是短暂的.
- 调整DBS参数或精神病药物可以改善这些AE.
- STN和GPi在情绪调节中发挥作用,而不仅仅是运动控制.
结论:
- 对患有PD的DBS患者来说,监测精神病学的结果至关重要.
- 需要提高对早期精神病并发症的认识和管理策略.
- 未来的研究应该标准化AE评估,并探索预防措施.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710

